Abstract
The prevalence of obesity is increasing globally, leading to significantly increased morbidity, mortality, and health care costs. However, there is a lack of effective treatment options that can treat patients with obesity less invasively than with bariatric surgery. Bariatric arterial embolization (BAE) is an image-guided, minimally invasive, percutaneous procedure that is currently being investigated in preclinical animal models and early clinical trials. If successful, BAE may represent a viable interventional approach for obesity treatment. The purpose of this article is to introduce the physiological and anatomical rationale for BAE, review techniques involved in performing BAE for weight modulation, and provide up-to-date preclinical evidence that supports the translation of BAE into patients.
Original language | English (US) |
---|---|
Article number | 100656 |
Journal | Techniques in Vascular and Interventional Radiology |
Volume | 23 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2020 |
Keywords
- Bariatric embolization
- Embolics
- Ghrelin
- Obesity
- Weight loss
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging